Skip to main content
Signal8

Vestal Point Capital, LP

Vestal Point Capital, LP is an Investment Adviser institutional filer with the SEC under CIK 1974915, reporting 68 portfolio positions, with 17 historical 13F filings on file. Most recent reporting period: 2026-06-30.

A Form 13F reports a manager's US-listed stock and option positions only. It does not include real estate, private funds, bonds, cash or non-US holdings, so a 13F portfolio value is not the firm's total assets under management (AUM).

  • State of incorporation: DE
  • Filing type: 13F-HR
  • Latest reporting period: 2026-06-30
  • Last filed: 2026-08-14

Top 10 portfolio positions

The largest reported holdings in Vestal Point Capital, LP's most recent 13F filing, ranked by reported market value.

  1. BioMarin Pharmaceutical Inc (BMRN)
  2. Neurocrine Biosciences Inc (NBIX)
  3. Abivax SA (ABVX)
  4. United Therapeutics Corp (UTHR)
  5. Enliven Therapeutics Inc (ELVN)
  6. Nurix Therapeutics Inc (NRIX)
  7. Bicara Therapeutics Inc (BCAX)
  8. Taysha Gene Therapies Inc (TSHA)
  9. Arrowhead Pharmaceuticals Inc (ARWR)
  10. Abbott Laboratories (ABT)
/